The steep rise in pharmaceutical prices year over year is old news at this point. Even a number of generic drugs are going up in price, causing difficulties for insurers…
The post Rising Pharmaceutical Costs a Major Challenge for Managed Healthca…
Rising Pharmaceutical Costs a Major Challenge for Managed Healthcare Read Post »
Annual Drug Patent Expirations for STARLIX Starlix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Novartis drug STARLIX appeared …
Pharmaceutical competition incorporates different tactics in different markets because countries have divergent approaches to regulating healthcare costs. Both price and product have roles in defining the competitive landscape in pharmaceuticals,……
Should Price or Product Be the Determinant in Pharmaceutical Competition? Read Post »
INVEGA SUSTENNA (paliperidone palmitate) Janssen pharms Patent: 6,077,843 Expiration: Nov 12, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug …
Drug Patent Expirations for the Week of November 12, 2017 Read Post »
Annual Drug Patent Expirations for PRELAY Prelay is a drug marketed by Sankyo and is included in one NDA. There are two patents protecting this drug. This drug has forty-five…
The post New patent expiration for Sankyo drug PRELAY appeared first o…
Annual Drug Patent Expirations for INVEGA+TRINZA Invega Trinza is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Janssen Pharms drug INVEGA TRINZA …
New patent expiration for Janssen Pharms drug INVEGA TRINZA Read Post »
INVEGA SUSTENNA (paliperidone palmitate) Janssen pharms Patent: 6,077,843 Expiration: Nov 12, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug …
Drug Patent Expirations for the Week of November 12, 2017 Read Post »
Annual Drug Patent Expirations for INVEGA+SUSTENNA Invega Sustenna is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Janssen Pharms drug INVEGA …
New patent expiration for Janssen Pharms drug INVEGA SUSTENNA Read Post »
Annual Drug Patent Expirations for ORBACTIV Orbactiv is a drug marketed by The Medicines Co and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for The Medicines drug ORBACTIV appeared fir…
New patent expiration for The Medicines drug ORBACTIV Read Post »
We live in a digital world. The way we interact has undergone a tremendous change in the last decade and this change is gradually reshaping our society itself. It’s difficult…
The post How can pharmaceutical companies play a key role in the digit…
Get new actionable insights and updates from BiotechBlog
